Letter from Konstantinos P. Letsas et al. - invited editorial comment.
Somberg
John
J
Molnar
Janos
J
D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008133:Long QT Syndrome / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D016171:Torsades de Pointes / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000139:chemically induced; D000077334:Zolpidem
D000889:Anti-Arrhythmia Agents; D006993:Hypnotics and Sedatives; D011725:Pyridines; D000077334:Zolpidem; D000638:Amiodarone